What happened
Fine Medix disclosed a supply contract with Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), worth US$483K, about 7.5% of its recent annual revenue, running through Oct 2026.
For context, this single contract equals about 7.5% of the company's most recent annual revenue.
| Counterparty | Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) |
|---|---|
| Contract value | US$483K |
| vs. recent revenue | 7.5% |
| Through | Oct 2026 (from Apr 2026) |
| Filed | 2026-04-16, Supply contract signed (voluntary) |
| Source | DART rcept 20260416900210 → open original filing |
Source: DART. Information only, not investment advice.